At a cumulative doxorubicin dose of 500 mg/m2, what is the approximate risk of cardiotoxicity?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the ONS ONCC Chemotherapy Exam. Enhance your skills with multiple choice questions and detailed explanations. Ensure you're ready for certification renewal!

Multiple Choice

At a cumulative doxorubicin dose of 500 mg/m2, what is the approximate risk of cardiotoxicity?

Explanation:
Doxorubicin causes damage to heart muscle in a dose-dependent way, so the higher the total amount given over treatment, the greater the risk of cardiotoxicity, which can lead to reduced heart function or heart failure and is often irreversible. Around a cumulative dose of 500 mg/m2, the risk has risen from low levels at smaller doses to a moderate range. Clinically, this is typically estimated in the vicinity of 6-20%, reflecting variability among patients and other risk factors. So at this dose, the risk is not near zero and not extreme; 6-20% best captures the expected probability.

Doxorubicin causes damage to heart muscle in a dose-dependent way, so the higher the total amount given over treatment, the greater the risk of cardiotoxicity, which can lead to reduced heart function or heart failure and is often irreversible. Around a cumulative dose of 500 mg/m2, the risk has risen from low levels at smaller doses to a moderate range. Clinically, this is typically estimated in the vicinity of 6-20%, reflecting variability among patients and other risk factors. So at this dose, the risk is not near zero and not extreme; 6-20% best captures the expected probability.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy